basketball-men-d1 flag

Jim Vertuno | The Associated Press | September 25, 2018

College basketball: Jones practicing with Texas after leukemia treatments

AUSTIN, Texas β€” Texas junior guard Andrew Jones is a limited participant in practice as he continues to regain strength following his diagnosis with leukemia, coach Shaka Smart said Monday.

Although Jones would probably like to play this season, Smart wasn't ready to say if he will be able to get on the court in a game. Jones is a full-time student.

RELATED: Texas' Smart talks Andrew Jones' progress, climb back onto court

"It's been great having him back. It's terrific seeing him back on the court and doing what he loves to do," Smart said. "He's participated in our workouts some. There's sometimes where he gets pulled out. The team doctor and the trainers want to make sure we're building back his strength before he gets thrown out there full time."

Texas announced on Jan. 10 that Jones had been diagnosed with leukemia after complaining of constantly feeling tired, and he didn't play the rest of last season. He underwent lengthy treatment at the University of Texas MD Anderson Cancer Center in Houston.

ALSO: 11 under-the-radar players to keep an eye on this season

Jones has remained engaged on social media, often relaying comments about his recovery and returning to campus, or posting videos of him playing basketball.

Jones lost "considerable" weight while undergoing treatment, Smart said.

"Andrew's a guy who has high expectations for himself. If he's out there he wants to be able to play like himself. We're excited about the growth he's making. There's more to come," Smart said. "I think he would like to (play), but we have to make sure we do what makes the most sense for him long term, and also what makes the most sense for our team."

MORE: 16 teams who have improved their stock over the summer

Texas opens the season Nov. 6 against Eastern Illinois.

This article was written by Jim Vertuno from The Associated Press and was legally licensed through the NewsCred publisher network. Please direct all licensing questions to legal@newscred.com.